Non-profit · founded 1989
Seattle Institute for Biomedical and Clinical Research
Seattle, United States · sibcr.org
- Citations, last 5 years
- 178
- Works, last 5 years
- 26
- h-index
- 50
- Scientists listed
- 0
- Grants since 2016
- 159
Grants received
2022–2025 · research · R01
Role of Astrocyte EAAT2/GLT1 Failure in Alzheimer's Disease Pathogenesis
David G Cook · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2021–2026 · research · R01
TDP-43 in Alzheimer's disease
Nicole Faron Liachko · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2021–2024 · research · R21
The Unfolding Role of Microglia in Alcohol Withdrawal
John F Neumaier · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2021–2026 · research · R01
TDP-43 in Alzheimer's disease
Nicole Faron Liachko · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2021–2026 · research · R01
TDP-43 in Alzheimer's disease
Nicole Faron Liachko · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2021–2024 · research · R01
Helping patients and physicians choose the appropriate surgery for end stage hallux rigidus
Daniel C Norvell · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2021–2026 · research · R01
Microglia and Opioid Withdrawal: Mechanisms of Negative Reinforcement
John F Neumaier · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2021–2026 · research · R01
Microglia and Opioid Withdrawal: Mechanisms of Negative Reinforcement
John F Neumaier · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2021–2023 · research · R21
User-centered Design and Evaluation of a Virtual Human Patient to Improve Safety Planning Skills
Aaron Martin Norr · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2021–2023 · research · R21
The Unfolding Role of Microglia in Alcohol Withdrawal
John F Neumaier · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2021 · research · R01
Investigating the role of lipid metabolism in protein aggregation and neurodegenerative disease progression
Marie Ynez Davis · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2021–2026 · research · R01
TDP-43 in Alzheimer's disease
Nicole Faron Liachko · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2021–2025 · research · R01
Helping patients and physicians choose the appropriate surgery for end stage hallux rigidus
Daniel C Norvell · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2021–2026 · research · R01
Microglia and Opioid Withdrawal: Mechanisms of Negative Reinforcement
John F Neumaier · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2021–2026 · research · R01
Microglia and Opioid Withdrawal: Mechanisms of Negative Reinforcement
John F Neumaier · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2021–2024 · research · R01
Helping patients and physicians choose the appropriate surgery for end stage hallux rigidus
Daniel C Norvell · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2021–2024 · research · R21
User-centered Design and Evaluation of a Virtual Human Patient to Improve Safety Planning Skills
Aaron Martin Norr · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2021–2027 · research · R01
TDP-43 in Alzheimer's disease
Nicole Faron Liachko · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2021–2027 · research · R01
Microglia and Opioid Withdrawal: Mechanisms of Negative Reinforcement
John F Neumaier · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2020–2025 · research · R01
Protection from pathological tau by activation of the ER unfolded protein response
Brian C. Kraemer · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2020–2025 · research · R01
Protection from pathological tau by activation of the ER unfolded protein response
Brian C. Kraemer · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2020–2025 · research · R01
Characterizing and Restoring Joint Motion in Patients with Hallux Rigidus
William R. Ledoux · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2020–2025 · research · R01
Characterizing and Restoring Joint Motion in Patients with Hallux Rigidus
William R. Ledoux · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2020–2025 · research · R01
Investigating the role of lipid metabolism in protein aggregation and neurodegenerative disease progression
Marie Ynez Davis · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2020–2025 · research · R01
Investigating the role of lipid metabolism in protein aggregation and neurodegenerative disease progression
Marie Ynez Davis · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2020–2023 · research · R21
Characterization of a human in vitro blood-brain barrier model to study the effects of systemic aging on responses to Alzheimer's disease effectors
Michelle A. Erickson · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2020–2025 · research · R01
Characterizing and Restoring Joint Motion in Patients with Hallux Rigidus
William R. Ledoux · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2020–2025 · research · R01
Protection from pathological tau by activation of the ER unfolded protein response
Brian C. Kraemer · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2020–2025 · research · R01
Characterizing and Restoring Joint Motion in Patients with Hallux Rigidus
William R. Ledoux · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2020–2025 · research · R01
Characterizing and Restoring Joint Motion in Patients with Hallux Rigidus
William R. Ledoux · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2020–2025 · research · R01
Protection from pathological tau by activation of the ER unfolded protein response
Brian C. Kraemer · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2020–2025 · research · R01
Investigating the role of lipid metabolism in protein aggregation and neurodegenerative disease progression
Marie Ynez Davis · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2020–2025 · research · R01
Investigating the role of lipid metabolism in protein aggregation and neurodegenerative disease progression
Marie Ynez Davis · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2020–2026 · research · R01
Protection from pathological tau by activation of the ER unfolded protein response
Brian C. Kraemer · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2020–2026 · research · R01
Investigating the role of lipid metabolism in protein aggregation and neurodegenerative disease progression
Marie Ynez Davis · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2019–2025 · research · R01
Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer
Shehzad Basaria · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2019–2025 · research · R01
Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer
Shehzad Basaria · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2019–2024 · research · R01
Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer
Shehzad Basaria · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2019–2026 · research · R01
Improving the Reach and Effectiveness of Smoking Cessation Services Targeted to Veterans Living with HIV
Sheryl L Catz · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2019–2021 · research · R56
Reversing tauopathy by inhibiting MSUT2 RNA-binding activity
Brian C. Kraemer · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
